Top Markets
#1 Pleasing Gold Pleasing Gold +1,463.60%
#2 PulseChain PulseChain +59.45%
#3 Merlin's Seal BTC Merlin's Seal BTC +33.17%
#4 BOOK OF MEME BOOK OF MEME +31.56%
#5 Ontology Gas Ontology Gas +27.50%
#6 Unit Pump Unit Pump +24.39%
#7 Pump.fun Pump.fun +24.39%
#8 Nockchain Nockchain +23.32%
#9 ConstitutionDAO ConstitutionDAO +21.69%
#10 Neiro Neiro +19.99%
Coin of the day
Pleasing Gold Pleasing Gold
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
NeoCore Technology Co., Ltd. NeoCore Technology Co., Ltd.

NeoCore Technology Co., Ltd.

4131
Clasificación en acciones #26466
NeoCore Technology Co., Ltd. is primarily engaged in the creation, manufacture,... NeoCore Technology Co., Ltd. is primarily engaged in the creation, manufacture, and distribution of biochips and advanced rapid nucleic acid hybridization devices. Their extensive product range features systems designed for food safety screening, human diagnostic arrays, agricultural analysis, and specific food examination arrays, in addition to a variety of laboratory instruments and DNA kits. The company further provides a suite of services, encompassing laboratory planning, design, and additional specialized support. Beyond its core biotech operations, NeoCore also participates in the wholesale and retail market for contact lenses. The firm, which was established in 1987 and is based in Tainan, Taiwan, underwent a name change in July 2023, transitioning from its former identity as DR. Chip Biotechnology Incorporation to its current name.
Precio por acción
$1.02
Capitalización bursátil
$40.42M
Cambio (1 día)
-1.08%
Cambio (1 año)
-10.53%
País
TW
Comercio NeoCore Technology Co., Ltd. (4131)

Categoría

Healthcare
Ingresos de NeoCore Technology Co., Ltd. (4131)
Ingresos en Aug 2026 TTM: 0
Según los últimos informes financieros de NeoCore Technology Co., Ltd., los ingresos actuales de la empresa (TTM) son 0. En 2026, la empresa obtuvo unos ingresos de 0 igual a los ingresos del año 2026, que fueron de 0. Los ingresos representan la cantidad total que una empresa genera por la venta de bienes o servicios. A diferencia de las ganancias, no se restan los gastos.
Historial de ingresos de NeoCore Technology Co., Ltd. desde 2026 hasta 2026
Ingresos al final de cada año
Año Ingresos Cambiar
Not enough data for the provided dates.
Ingresos de empresas similares o competidoras
Empresa Ingresos Diferencia de ingresos País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.70B -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $2.23B -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH